DrugDashboards

Atropine Sulfate

Atropine Sulfate · ATROPINE SULFATE .1 mg/mL · Injection · Intravenous · ProPharma Distribution

NDC 84549-0340-01 · 10 mL in 1 SYRINGE · ANDA · View full market →

The short version

8 companies supply this market — a reasonable cushion if one runs into trouble. It is in shortage right now — FDA lists the reason as “discontinuation of the manufacture of the drug”.

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

Medicare Part D

No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.

How Part D pricing works →

NADAC price per unit

No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.

Supply fragility

Not scored — fragility is computed for NADAC-priced NDCs.

Where it's made

Establishments this product's FDA label declares, located via FDA registration data. How we built this →

Is this a "specialty" drug?

There's no legal definition — it meets 1 of 6 public criteria. Why that matters →

  • Part D specialty tier
  • Costs ≥ $950/fill · avg $47.18 per prescription
  • Biologic (BLA)
  • Injectable / infused
  • Orphan-drug exclusivity
  • REMS program

Regulatory

Application
ANDA212461
TE code
AP
Approval date
Oct 5, 2020
Patents / exclusivity
None on file

Shortage history

  • In shortage now — Atropine Sulfate, Injection, 0.4 mg/1 mL (NDC 0641-6251-10)Dec 20, 2023
    month 33 of a typical 20 for injectable shortages · model puts 22% odds it resolves within 6 months
  • In shortage now — Atropine Sulfate, Injection, .05 mg/1 mL (NDC 16729-483-03)Jan 1, 2020
    Discontinuation of the manufacture of the drug
    month 81 — 4× the typical 20-month injectable shortage · model puts 22% odds it resolves within 6 months
  • In shortage now — Atropine Sulfate, Injection, .1 mg/1 mL (NDC 16729-484-90)Jan 1, 2020
    Discontinuation of the manufacture of the drug
    month 81 — 4× the typical 20-month injectable shortage · model puts 22% odds it resolves within 6 months
  • In shortage now — Atropine Sulfate, Injection, .1 mg/1 mL (NDC 76329-3340-1)Jan 1, 2020
    month 81 — 4× the typical 20-month injectable shortage · model puts 22% odds it resolves within 6 months
  • In shortage now — Atropine Sulfate, Injection, 0.1 mg/1 mL (NDC 16729-484-45)Jan 1, 2020
    month 81 — 4× the typical 20-month injectable shortage · model puts 22% odds it resolves within 6 months

Recalls (this NDC)

No enforcement reports list this package NDC.

Manufacturers of Atropine Sulfate (Injection)

LabelerStrengthFirst seenLast seen
Hikma Pharmaceuticals USA Inc.ATROPINE SULFATE .4 mg/mLJul 15, 2026Sep 3, 2026
Medical Purchasing Solutions, LLCATROPINE SULFATE .4 mg/mLJul 15, 2026Sep 3, 2026
A-S Medication SolutionsATROPINE SULFATE .1 mg/mLJul 15, 2026Sep 2, 2026
Accord Healthcare, Inc.,ATROPINE SULFATE .05 mg/mLJul 15, 2026Sep 2, 2026
Accord Healthcare, Inc.,ATROPINE SULFATE .1 mg/mLJul 15, 2026Sep 2, 2026
HF Acquisition Co LLC, DBA HealthFirstATROPINE SULFATE .1 mg/mLJul 15, 2026Sep 2, 2026
Hikma Pharmaceuticals USA Inc.ATROPINE SULFATE 1 mg/mLJul 15, 2026Sep 2, 2026
International Medication Systems, LimitedATROPINE SULFATE .1 mg/mLJul 15, 2026Sep 2, 2026
ProPharma DistributionATROPINE SULFATE .1 mg/mLJul 15, 2026Sep 2, 2026
Remedyrepack Inc.ATROPINE SULFATE .1 mg/mLJul 15, 2026Sep 2, 2026
Remedyrepack Inc.ATROPINE SULFATE .4 mg/mLJul 15, 2026Sep 2, 2026
HF Acquisition Co LLC, DBA HealthFirstATROPINE SULFATE .4 mg/mLJul 15, 2026Aug 31, 2026
Medical Purchasing Solutions, LLCATROPINE SULFATE .1 mg/mLJul 15, 2026Aug 31, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "Atropine Sulfate — NDC 84549-0340-01," retrieved September 3, 2026, https://drugdashboards.com/drug/84549034001.

Free to cite with attribution — see how the data is put together.